The Association between HLADRB1*1501, IL7Ra, and APOE Polymorphism and MS in Iranian Population

Document Type : Original paper


Department of Biology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran


Background and aim: Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. Despite many research carried out to find the pathogenesis of this disease, the MS pathogenesis is still unclear. The association of HLA-DRB1*1501 with MS risk has been investigated in many populations. This study aimed to investigate the association of HLADRB1*1501, IL7Ra, and APOE polymorphism genes with MS in patients in Tehran. Materials and methods: The participants in this study were selected from the neurology department of Shariati Hospital in Tehran (30 patients with MS), and 30 healthy blood donors from the Tehran Blood Transfusion Center (control group). Blood samples were obtained and DNA was extracted using the PCR method. The genotype was determined using the sequencing approach. Results: A significant association was identified between these polymorphisms in the patient and control groups in the HLADRB1*1501 gene, G allele (p = 0.000), and in the IL7Ra gene, T allele (p=0.022). However, the PCR results for the APOE gene were unfavorable for sequencing, and the genotype was not determined. Conclusion: The findings of this study revealed that the polymorphism of the 1501*HLADRB1 and IL7Ra genes in the Tehran patient population was similar to the European population.


  1. [1]. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and

    neurodegeneration. Neuron. 2006;52(1):61-76.

    [2]. Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors,

    prodromes, and potential causal pathways. The Lancet Neurology. 2010;9(7):727-39.

    [3]. Calabresi PA. Diagnosis and management of multiple sclerosis. American family physician.


    [4]. Tamam Y, Tasdemir N, Yalman M, Tamam B. Association of apolipoprotein E genotypes

    with prognosis in multiple sclerosis. Eur Rev Med Pharmacol Sci. 2011;15(10):1122-30.

    [5]. Losonzci E. Investigation in the hungarian multiple scrolosis patient thesis.


    [6]. Haj MS, Nikravesh A, Kakhki MP, Rakhshi N. Association study of four polymorphisms in

    the interleukin-7 receptor alpha gene with multiple sclerosis in Eastern Iran. Iranian journal of

    basic medical sciences. 2015;18(6):593.

    [7]. Hadavi V, Farhoud D, HASHEMZADEH CM, SANATI M, HUSHMAND M, Nabavi SM,

    Younesian M, Seyedian M. Association of apolipoprotein E polymorphism with susceptibility to

    multiple sclerosis. Iranian Journal of Biotechnology. 2004;2(1):49-54.

    [8]. Al-Shammri S, Fatania H, Al-Radwan R, Akanji AO. The relationship of APOE genetic

    polymorphism with susceptibility to multiple sclerosis and its clinical phenotypes in Kuwaiti Arab

    subjects. Clinica Chimica Acta. 2005;351(1-2):203-7.

    [9]. Martins Da Silva A, Cavaco S, Moreira I, Bettencourt A, Santos E, Pinto C, Gonçalves A,

    Coutinho E, Samões R, Dias CC, Teixeira-Pinto A. Cognitive reserve in multiple sclerosis: Protective effects of education. Multiple Sclerosis Journal. 2015;21(10):1312-21.

    [10]. Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and

    multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. The Lancet Neurology. 2015;14(3):263-73.

    [11]. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S, Stewart GJ, Broadley S, Scott RJ,

    Booth DR, Lechner-Scott J, ANZgene Multiple Sclerosis Genetics Consortium. MicroRNAs miR[1]17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PloS

    one. 2010;5(8):e12132.

    [12]. Lu LF, Liston A. MicroRNA in the immune system, microRNA as an immune system.

    1. Ghorbani / Intl J of BiolIfe Sciences: 1(3) 119-127, 2022; 127Immunology. 2009;127(3):291-8.

    [13]. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo

    C, Ferracin M, Prueitt RL. A microRNA expression signature of human solid tumors defines

    cancer gene targets. Proceedings of the National Academy of Sciences. 2006;103(7):2257-61.

    [14]. Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free

    microRNAs in cancer. Nature reviews Clinical oncology. 2014;11(3):145-56.

    [15]. Hashemi M, Moradi N, Ziaee SA, Narouie B, Soltani MH, Rezaei M, Shahkar G, Taheri M.

    Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and

    miR-149 and prostate cancer risk in a sample of Iranian population. Journal of advanced research.


    [16]. Li C, Fu W, Zhang Y, Zhou L, Mao Z, Lv W, Li J, Zhou Y. Meta-analysis of microRNA[1]146a rs2910164 G> C polymorphism association with autoimmune diseases susceptibility, an update based on 24 studies. PloS one. 2015;10(4):e0121918.

    [17]. Benešová Y, Vašků A, Štourač P, Hladíková M, Fiala A, Bednařík J. Association of HLA[1]DRB1* 1501 tagging rs3135388 gene polymorphism with multiple sclerosis. Journal of

    neuroimmunology. 2013;255(1-2):92-6.

    [18]. Omraninava M, Mehranfar S, Vahedi P, Razi B, Imani D, Aslani S, Feyzinia S. Association

    between IL7 Receptor Alpha (Il7ra) gene rs6897932 polymorphism and the risk of Multiple

    Sclerosis: A meta-regression and meta-analysis. Multiple sclerosis and related disorders.


    [19]. Stanković A, Dinčić E, Ristić S, Lovrečić L, Starčević Cizmarević N, Djurić T, Sepčić J,

    Kapović M, Raičević R, Peterlin B, Alavantić D. Interleukin 7 receptor alpha polymorphism

    rs6897932 and susceptibility to multiple sclerosis in the Western Balkans. Multiple Sclerosis

    Journal. 2010;16(5):533-6.

    [20]. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder

    LP, Saarela J, Harbo HF, Celius EG. Variation in interleukin 7 receptor α chain (IL7R) influences

    risk of multiple sclerosis. Nature genetics. 2007;39(9):1108-13.

    [21]. Yoshimura S. The Genetics of Multiple Sclerosis and Neuromyelitis Optica in Japan. Journal

    of Neurological Disorders & Stroke. 2014;2(4):1079

Volume 1, Issue 3
(Special Issue: papers selected from ICLS22, Istanbul, Turkey)
Pages 119-127
  • Receive Date: 06 September 2022
  • Revise Date: 10 September 2022
  • Accept Date: 02 October 2022